September 27, 2016 10:54 PM ET

Pharmaceuticals

Company Overview of Bristol-Myers Squibb Pharmaceuticals Limited

Company Overview

Bristol-Myers Squibb Pharmaceuticals Limited discovers, develops, and distributes pharmaceutical products. It offers products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company also provides pharmaceutical products for Alzheimer’s disease, atherosclerosis/thrombosis, cancers, hepatitis, HIV/AIDS, obesity, psychiatric disorders, rheumatoid arthritis and related diseases, solid organ transplant rejection, and immuno-oncology. The company was founded in 1990 and is based in Uxbridge, United Kingdom. Bristol-Myers Squibb Pharmaceuticals Limited operates as a subsidiary of Bristol-Myers Squibb Company.

BMS House

Uxbridge Business Park

Sanderson Road

Uxbridge,  UB8 1DH

United Kingdom

Founded in 1990

Phone:

44 1895 523 000

Fax:

44 1895 523 010

Key Executives for Bristol-Myers Squibb Pharmaceuticals Limited

Chief Executive Officer
Age: 65
Chief Scientific Officer, Executive Vice President and President of R&D
Age: 64
Senior Vice President and Head of Development for Oncology
Head of Communications
General Manager
Compensation as of Fiscal Year 2016.

Bristol-Myers Squibb Pharmaceuticals Limited Key Developments

Bristol-Myers Squibb Pharmaceuticals Ltd. Wins GBP 696.9 Million Multiple Awardees Contract

Bristol-Myers Squibb Pharmaceuticals Ltd. won a GBP 696.9 million multiple awardees contract award from The Secretary of State for Health acting as part of the Crown through the Commercial Medicines Unit (part of the Department of Health) for pharmaceutical products (Tranche A including Hepatitis C) (Contract Award Notice No.: 2016/S 158-286599).

Bristol-Myers Squibb Pharmaceuticals Limited Wins GBP 150 Million Multiple Awardees Contract for Branded Pharmaceuticals

Bristol-Myers Squibb Pharmaceuticals Ltd. won a GBP 150 million (excluding VAT) multiple awardees contract award from The Secretary of State for Health acting as part of the Crown through the Commercial Medicines Unit (part of the Department of Health) for branded pharmaceuticals.

Bristol-Myers Squibb Pharmaceuticals Wins GBP 106.5 Million Multiple Awardees Contract for Proprietary Pharmaceuticals

Bristol-Myers Squibb Pharmaceuticals Ltd. announced that it has won a GBP 106.5 million multiple awardees contract award from The Secretary of State for Health acting as part of the Crown through the Commercial Medicines Unit (part of the Department of Health) for proprietary pharmaceuticals (Contract Award Notice No.: 2016/S 044-072447).

Similar Private Companies By Industry

Company Name Region
Abbey Pharma Limited Europe
Absynth Biologics Limited Europe
Acacia Pharma Limited Europe
AccentBio Ltd. Europe
Aclar Limited Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Bristol-Myers Squibb Pharmaceuticals Limited, please visit www.b-ms.co.uk. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.